Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial

Autor: Christian Lucas, Claude Dubray, Noémie Delage, Christelle Créac’h, G. Mick, M. Letellier, E. Serra, Damien Richard, Pascale Picard, A. Hamdani, Alain Eschalier, S. Soriot‐Thomas, P. Arcagni, Pascale Vergne-Salle, V. Martinez, Michel Lantéri-Minet, D. Delbrouck, E. Bozzolo, C. Maindet, C. Dualé, Christian Gov, H. Alchaar, Nicolas Kerckhove, Bruno Pereira, D. Lefebvre‐Kuntz, Céline Lambert, S. Romettino, L. Balp, N. Leroux‐Bromberg, E. Piquet, C. Brosse, Christophe Mallet, Lise Bernard, F. Marcaillou, Y. Perier, V.S. Hieng, B. Lietar, R. Deleens, M. Navez, D. Gillet, E. Kuhn

Publikováno v: European Journal of Pain
European Journal of Pain, 2018, 22 (7), pp.1321-1330. ⟨10.1002/ejp.1221⟩
European Journal of Pain, Wiley, 2018, 22 (7), pp.1321-1330. ⟨10.1002/ejp.1221⟩

Background T‐type calcium channels have been shown to play an important role in the initiation and maintenance of neuropathic pain and represent a promising therapeutic target for new analgesic treatments. Ethosuximide (ETX), an anticonvulsant and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e7e7c5827e586dc1070ee416c99f109
https://doi.org/10.1002/ejp.1221

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.